Events › B2B Event
B2B Event
14th edition
210
Attendees
The 14th Tumor Models Summit Boston is a premier oncology preclinical conference focusing on translational strategies for in vitro, in vivo, ex vivo, and complex tumor modeling to accelerate drug development.
Exhibitor mix: Partners listed by sponsorship tier (Lead, Innovation, Expertise) and general partners.
Filter this event to your ICP.
Dozens of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Organizer
Hanson WadePE-backed · London, United Kingdom · Founded 2008
Hanson Wade is a global conference organizer and market intelligence provider focused primarily on the life sciences and biopharma sectors.
Why people attend
To source novel translational model technologies, contract research services for oncology, and benchmark strategies with biopharma peers.
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
Speakers
28 speakers at Tumor Models Boston Summit
Chief Scientific Officer · XenoSTART
"From Treatment to Translation: Tailored PDX models from Patients Pretreated with Approved & Investigational Cancer Therapies"
Senior Director, Biological Modeling · Tempus AI
"Unlocking Insights: Integrating Patient-Derived Organoid Models & Real- World Data to Drive Discovery & De-Risk Translational Research"
Also speaking at Aspen Ideas Festival
Research Scientist · XYLYX Bio
"TissueSpec® Bone, Liver & Lung dECM Hydrogels for Modeling Organotropic Breast Cancer Metastasis"
Principal Scientist - RLT Modeling & Simulation · Novartis
"Applying PBPK Modelling to Empower Translational Development for Radioligand Therapies (RLTs)"
Senior VP Head of Research & Development · Synaptimmune Therapeutics
"Accelerating T‑Cell Engager & Co‑Stimulatory Therapeutics Through Patient‑Centric Tumor Model Integration"
Also speaking at 17th World Bispecific Summit US
Senior Scientist · Regeneron
"Building an IND Package Leveraging In Vitro Only Data for Cell Therapy"
Scientist · Merck & Co.
"Development of a Tumoroid Screening Platform to Empower Oncology Drug Development"
Zixiong Wang (Mervin) is a Scientist in the Department of Quantitative Biosciences (QB) at the Merck Boston site. He completed both his undergraduate and graduate studies at Boston University. Under the mentorship of Dennis Jones, PhD, Associate Professor in the Department of Pathology & Laboratory Medicine, he conducted research focused on T cell trafficking within tumors and the generation of CAR-T cells. After joining Merck, Mervin has supported multiple QB programs and developed extensive expertise in assay development using organoids and tumoroids. He has also contributed to the development of high-throughput drug screening platforms utilizing tumoroid models.
Senior Director - Clinical Bioanalytics & Translational Science · Beam Therapeutics
"Exploring a Translational Biomarker Framework for Cell & Gene Therapies"
Principal Scientist · Agenus
"Leveraging Colorectal Cancer (CRC) Liver-Metastatic Organoid Models to Advance Immunotherapy Development"
Scientific Director, Research Fellow, Oncology Translational Research, Lead Engineering & Technical · AbbVie
Translational Science Senior Scientist (Non-Clinical Biomedical Sciences) · Astellas
Director - Tumor Immunobiology, Clinical ICC Discovery Group, Oncology Research & Development · AstraZeneca
Associate Principal Scientist · Bayer
Director, Innovative Medicine Oncology · Johnson & Johnson
Associate Director, Oncology Biomedical Research · Novartis
Principal Scientist & Manager · Regeneron
+ 12 more speakers at this event.
More events in United States
Frequently asked questions